The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia.
作者信息
Cillóniz Catia, Torres Antoni, Garcia-Vidal Carolina, Moreno-Garcia Estela, Amaro Rosanel, Soler Nestor, Marcos M Angeles, Rico Verónica, Gabarrús Albert, Nicolás Josep María, Soriano Alex
机构信息
Department of Pneumology, Hospital Clínic of Barcelona; August Pi i Sunyer Biomedical Research Institute - IDIBAPS, University of Barcelona; Biomedical Research Networking Centers in Respiratory Diseases (CIBERES) Barcelona, Barcelona, Spain.
Department of Infectious Diseases, Hospital Clínic of Barcelona, Barcelona, Spain.
出版信息
Arch Bronconeumol. 2021 Jan;57:79-82. doi: 10.1016/j.arbres.2020.07.038. Epub 2020 Sep 6.
Abstract
摘要
相似文献
1
The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia.
Arch Bronconeumol. 2021 Jan;57:79-82. doi: 10.1016/j.arbres.2020.07.038. Epub 2020 Sep 6.
2
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
3
Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Int J Lab Hematol. 2021 Apr;43(2):329-335. doi: 10.1111/ijlh.13374. Epub 2020 Oct 25.
4
Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia.
Intensive Care Med. 2020 Sep;46(9):1707-1713. doi: 10.1007/s00134-020-06186-0. Epub 2020 Jul 29.
5
Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
Crit Care. 2020 Nov 26;24(1):666. doi: 10.1186/s13054-020-03332-4.
6
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
7
Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.
Am J Emerg Med. 2021 Feb;40:110-114. doi: 10.1016/j.ajem.2020.11.058. Epub 2020 Dec 6.
8
Diarrhea Is Associated With Prolonged Symptoms and Viral Carriage in Corona Virus Disease 2019.
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1753-1759.e2. doi: 10.1016/j.cgh.2020.04.030. Epub 2020 Apr 18.
9
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
J Immunol. 2020 Nov 1;205(9):2437-2446. doi: 10.4049/jimmunol.2000717. Epub 2020 Sep 2.
10
Clinical features and predictors for patients with severe SARS-CoV-2 pneumonia at the start of the pandemic: a retrospective multicenter cohort study.
BMC Infect Dis. 2021 Jul 8;21(1):666. doi: 10.1186/s12879-021-06335-w.
引用本文的文献
1
Association Between C-Reactive Protein to Lymphocyte Ratio and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1915-1925. doi: 10.2147/COPD.S510755. eCollection 2025.
2
The relationship between C-reactive protein to lymphocyte ratio and the prevalence of chronic kidney disease in US adults: a cross-sectional study.
Front Endocrinol (Lausanne). 2025 Jan 15;15:1469750. doi: 10.3389/fendo.2024.1469750. eCollection 2024.
3
Associations of C-reactive protein to lymphocyte ratio and metabolic-dysfunction-associated steatotic liver disease: evidence from NHANES 2017-2018.
BMC Gastroenterol. 2024 Dec 24;24(1):475. doi: 10.1186/s12876-024-03458-7.
4
Can C-Reactive Protein-Lymphocyte Ratio Be Used as a Screening Tool to Confirm the Diagnosis of Periprosthetic Joint Infection?
Clin Orthop Surg. 2023 Dec;15(6):917-927. doi: 10.4055/cios22313. Epub 2023 Oct 23.
5
The relationship between C-reactive protein to lymphocyte ratio and the prevalence of myocardial infarction in US adults: A cross-sectional study.
Heliyon. 2023 Jun 29;9(7):e17776. doi: 10.1016/j.heliyon.2023.e17776. eCollection 2023 Jul.
6
Lymphocyte-to-C-Reactive Protein Ratio as an Early Sepsis Biomarker for Neonates with Suspected Sepsis.
Mediators Inflamm. 2023 May 8;2023:9077787. doi: 10.1155/2023/9077787. eCollection 2023.
7
Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study.
Hippokratia. 2022 Apr-Jun;26(2):70-77.
8
A scoring system developed from a nomogram to differentiate active pulmonary tuberculosis from inactive pulmonary tuberculosis.
Front Cell Infect Microbiol. 2022 Sep 2;12:947954. doi: 10.3389/fcimb.2022.947954. eCollection 2022.
9
Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis.
Front Immunol. 2022 Jun 27;13:870632. doi: 10.3389/fimmu.2022.870632. eCollection 2022.
10
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
本文引用的文献
1
Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
J Med Virol. 2020 Oct;92(10):1733-1734. doi: 10.1002/jmv.25819. Epub 2020 Apr 8.
2
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Obesity and the risk and outcome of infection.
Int J Obes (Lond). 2013 Mar;37(3):333-40. doi: 10.1038/ijo.2012.62. Epub 2012 May 1.
7
Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays.
Chest. 2007 Jun;131(6):1735-41. doi: 10.1378/chest.06-2233. Epub 2007 May 2.
Zotero 插件